AI Analysis AI Analysis of PCVX AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add PCVX to Watchlist?
Some Reasons Why To Add PCVX:
  • Low bankruptcy risk (Altman Z-Score: 12.24)
  • Bullish trend confirmed on both short and long timeframes
  • Highly efficient cash conversion (100% FCF/OCF ratio)
PDF

Weaker technical forecast for Vaxcyte, Inc. as stock downgraded to Sell Candidate
(Updated on Jul 29, 2026)

Sell candidate since Jul 29, 2026

The Vaxcyte, Inc. stock price fell by -2.97% on the last day (Wednesday, 29th Jul 2026) from $54.60 to $52.98. During the last trading day the stock fluctuated 5.13% from a day low at $52.47 to a day high of $55.16. The price has fallen in 7 of the last 10 days and is down by -6.63% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -79 thousand shares and in total, 1 million shares were bought and sold for approximately $60.50 million.

The stock lies in the middle of a very wide and weak rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 9.17% during the next 3 months and, with a 90% probability hold a price between $52.66 and $67.73 at the end of this 3-month period.

PCVX Signals & Forecast

There are few to no technical positive signals at the moment. The Vaxcyte, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. On corrections up, there will be some resistance from the lines at $55.35 and $54.46. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Tuesday, July 07, 2026, and so far it has fallen -12.68%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.

Support, Risk & Stop-loss for Vaxcyte, Inc. stock

Vaxcyte, Inc. finds support from accumulated volume at $51.48 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $2.69 between high and low, or 5.13%. For the last week, the stock has had daily average volatility of 3.89%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (PCVX) For The Upcoming Trading Day Of Thursday 30th

For the upcoming trading day on Thursday, 30th we expect Vaxcyte, Inc. to open at $53.54, and during the day (based on 14 day Average True Range), to move between $51.82 and $54.14, which gives a possible trading interval of +/-$2.33 (+/-4.49%) up or down from last closing price. If Vaxcyte, Inc. takes out the full calculated possible swing range there will be an estimated 4.49% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $51.48 (2.83%) than the resistance at $55.64 (5.02%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Earnings coming up

Vaxcyte, Inc. will release earnings BMO on Wednesday, August 05, 2026.The consensus among the analysts for the expected earnings (EPS) is -$2.06. We will update the financials statements for Vaxcyte, Inc., that can be found here as soon as the records are public. Our systems has calculated a possible swing of +/- 4.93% in the first trading day after earnings release.

Is Vaxcyte, Inc. stock A Buy?

The Vaxcyte, Inc. stock holds several negative signals and despite the positive trend, we believe Vaxcyte, Inc. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Sell candidate.

Current score: -4.921 Sell Candidate Downgraded

Predicted Fair Opening Price

Predicted fair opening price on July 30, 2026 - $53.54 ( 1.05%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

PCVX Performance

Trading levels for PCVX

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 56.23 6.13%
R2 55.20 4.19%
R1 54.56 2.99%
Price 52.98
S1 52.51 -0.89%
S2 51.87 -2.09%
S3 50.85 -4.03%

Accumulated Volume Support & Resistance Levels

Level Price
R3 57.72 8.95%
R2 56.52 6.68%
R1 55.64 5.02%
Price 52.98
S1 51.48 -2.83%
S2 51.44 -2.91%
S3 47.17 -10.97%

FAQ

What is the symbol for Vaxcyte, Inc. Stock and on which exchange is it traded?
The symbol for Vaxcyte, Inc. is PCVX and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Vaxcyte, Inc. Stock?
The Vaxcyte, Inc. stock holds several negative signals and despite the positive trend, we believe Vaxcyte, Inc. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Sell candidate.

How to buy Vaxcyte, Inc. Stock?
Vaxcyte, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Vaxcyte, Inc. Stock.

What's the current price of Vaxcyte, Inc. Stock?
As of the end of day on the Jul 29, 2026, the price of an Vaxcyte, Inc. (PCVX) share was $52.98.

What is the 52-week high and low for Vaxcyte, Inc. Stock?
The 52-week high for Vaxcyte, Inc. Stock is $64.79 and the 52-week low is $29.10.

What is the market capitalization of Vaxcyte, Inc. Stock?
As of the Jul 29, 2026, the market capitalization of Vaxcyte, Inc. is 7.65B.

When is the next earnings date for Vaxcyte, Inc.?
The upcoming earnings date for Vaxcyte, Inc. is Aug 05, 2026.
Click to get the best stock tips daily for free!
ABOUT VAXCYTE, INC.
Vaxcyte
Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 clinical trials to treat invasive pneumococcal disease and pneumonia. The company also develops VAX-XP to protect against emerging strains and address antibiotic resistance; VAX-A1, a co...
GOLDEN STAR
Ticker Change Signal Date
UNFI
$49.05
2.26% Jul 27
FOX
$50.81
3.78% Jul 27
BIIB
$202.19
3.48% Jul 24
A
AVS
$7.74
3.10% Jul 24
TSCO
$30.32
2.24% Jul 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE